Disparities	O
in	O
treatment	O
and	O
survival	O
for	O
women	B:C0043210
with	O
endometrial	O
cancer	I:C0007103
:	O
A	O
contemporary	O
national	O
cancer	I:C0242481
database	I:C0242481
registry	I:C0242481
analysis	I:C0242481
.	O

Disparities	O
in	O
treatment	O
and	O
survival	O
for	O
women	O
with	O
endometrial	B:C0007103
cancer	I:C0007103
:	O
A	O
contemporary	O
national	O
cancer	I:C0242481
database	I:C0242481
registry	I:C0242481
analysis	I:C0242481
.	O

Disparities	O
in	O
treatment	O
and	O
survival	O
for	O
women	O
with	O
endometrial	O
cancer	I:C0007103
:	O
A	O
contemporary	O
national	B:C0242481
cancer	I:C0242481
database	I:C0242481
registry	I:C0242481
analysis	I:C0242481
.	O

The	O
study	O
aim	O
was	O
to	O
identify	O
contemporary	O
socioeconomic	O
,	O
racial	O
,	O
ethnic	O
,	O
and	O
facility	O
-	O
related	O
factors	O
associated	O
with	O
stage	B:C1514952
at	I:C1514952
diagnosis	I:C1514952
,	O
receipt	O
of	O
cancer	O
treatment	O
,	O
and	O
survival	O
in	O
women	O
with	O
endometrial	O
cancer	I:C0007103
(	O
endometrial	O
cancer	I:C0007103
)	O
.	O

The	O
study	O
aim	O
was	O
to	O
identify	O
contemporary	O
socioeconomic	O
,	O
racial	O
,	O
ethnic	O
,	O
and	O
facility	O
-	O
related	O
factors	O
associated	O
with	O
stage	O
at	I:C1514952
diagnosis	I:C1514952
,	O
receipt	B:C0282574
of	O
cancer	O
treatment	O
,	O
and	O
survival	O
in	O
women	O
with	O
endometrial	O
cancer	I:C0007103
(	O
endometrial	O
cancer	I:C0007103
)	O
.	O

The	O
study	O
aim	O
was	O
to	O
identify	O
contemporary	O
socioeconomic	O
,	O
racial	O
,	O
ethnic	O
,	O
and	O
facility	O
-	O
related	O
factors	O
associated	O
with	O
stage	O
at	I:C1514952
diagnosis	I:C1514952
,	O
receipt	O
of	O
cancer	B:C0006826
treatment	O
,	O
and	O
survival	O
in	O
women	O
with	O
endometrial	O
cancer	I:C0007103
(	O
endometrial	O
cancer	I:C0007103
)	O
.	O

The	O
study	O
aim	O
was	O
to	O
identify	O
contemporary	O
socioeconomic	O
,	O
racial	O
,	O
ethnic	O
,	O
and	O
facility	O
-	O
related	O
factors	O
associated	O
with	O
stage	O
at	I:C1514952
diagnosis	I:C1514952
,	O
receipt	O
of	O
cancer	O
treatment	O
,	O
and	O
survival	O
in	O
women	B:C0043210
with	O
endometrial	O
cancer	I:C0007103
(	O
endometrial	O
cancer	I:C0007103
)	O
.	O

The	O
study	O
aim	O
was	O
to	O
identify	O
contemporary	O
socioeconomic	O
,	O
racial	O
,	O
ethnic	O
,	O
and	O
facility	O
-	O
related	O
factors	O
associated	O
with	O
stage	O
at	I:C1514952
diagnosis	I:C1514952
,	O
receipt	O
of	O
cancer	O
treatment	O
,	O
and	O
survival	O
in	O
women	O
with	O
endometrial	B:C0007103
cancer	I:C0007103
(	O
endometrial	O
cancer	I:C0007103
)	O
.	O

The	O
study	O
aim	O
was	O
to	O
identify	O
contemporary	O
socioeconomic	O
,	O
racial	O
,	O
ethnic	O
,	O
and	O
facility	O
-	O
related	O
factors	O
associated	O
with	O
stage	O
at	I:C1514952
diagnosis	I:C1514952
,	O
receipt	O
of	O
cancer	O
treatment	O
,	O
and	O
survival	O
in	O
women	O
with	O
endometrial	O
cancer	I:C0007103
(	O
endometrial	B:C0007103
cancer	I:C0007103
)	O
.	O

Women	B:C0043210
diagnosed	O
with	O
endometrial	O
cancer	I:C0007103
between	O
1998	O
and	O
2010	O
were	O
identified	O
from	O
the	O
National	O
Cancer	I:C0242356
Database	I:C0242356
.	O

Women	O
diagnosed	O
with	O
endometrial	B:C0007103
cancer	I:C0007103
between	O
1998	O
and	O
2010	O
were	O
identified	O
from	O
the	O
National	O
Cancer	I:C0242356
Database	I:C0242356
.	O

Women	O
diagnosed	O
with	O
endometrial	O
cancer	I:C0007103
between	O
1998	O
and	O
2010	O
were	O
identified	O
from	O
the	O
National	B:C0242356
Cancer	I:C0242356
Database	I:C0242356
.	O

Variables	O
associated	O
with	O
the	O
outcomes	O
of	O
interest	O
were	O
assessed	O
using	O
multivariable	B:C0010235
Cox	I:C0010235
proportional	I:C0010235
hazards	I:C0010235
and	O
logistic	O
regression	I:C0206031
.	O

Variables	O
associated	O
with	O
the	O
outcomes	O
of	O
interest	O
were	O
assessed	O
using	O
multivariable	O
Cox	I:C0010235
proportional	I:C0010235
hazards	I:C0010235
and	O
logistic	B:C0206031
regression	I:C0206031
.	O

Among	O
228,511	O
women	B:C0043210
identified	O
,	O
the	O
percentage	O
of	O
blacks	O
with	O
stage	O
IIIC	I:C1514952
/	I:C1514952
IV	I:C1514952
disease	I:C1514952
at	I:C1514952
diagnosis	I:C1514952
was	O
nearly	O
twice	O
that	O
of	O
non-Hispanic	O
whites	I:C1257890
(	O
17.8	O
%	O
vs	O
9.8	O
%	O
;	O
P	O
<	O
0.001	O
)	O
.	O

Among	O
228,511	O
women	O
identified	O
,	O
the	O
percentage	O
of	O
blacks	B:C0005680
with	O
stage	O
IIIC	I:C1514952
/	I:C1514952
IV	I:C1514952
disease	I:C1514952
at	I:C1514952
diagnosis	I:C1514952
was	O
nearly	O
twice	O
that	O
of	O
non-Hispanic	O
whites	I:C1257890
(	O
17.8	O
%	O
vs	O
9.8	O
%	O
;	O
P	O
<	O
0.001	O
)	O
.	O

Among	O
228,511	O
women	O
identified	O
,	O
the	O
percentage	O
of	O
blacks	O
with	O
stage	B:C1514952
IIIC	I:C1514952
/	I:C1514952
IV	I:C1514952
disease	I:C1514952
at	I:C1514952
diagnosis	I:C1514952
was	O
nearly	O
twice	O
that	O
of	O
non-Hispanic	O
whites	I:C1257890
(	O
17.8	O
%	O
vs	O
9.8	O
%	O
;	O
P	O
<	O
0.001	O
)	O
.	O

Among	O
228,511	O
women	O
identified	O
,	O
the	O
percentage	O
of	O
blacks	O
with	O
stage	O
IIIC	I:C1514952
/	I:C1514952
IV	I:C1514952
disease	I:C1514952
at	I:C1514952
diagnosis	I:C1514952
was	O
nearly	O
twice	O
that	O
of	O
non-Hispanic	B:C1257890
whites	I:C1257890
(	O
17.8	O
%	O
vs	O
9.8	O
%	O
;	O
P	O
<	O
0.001	O
)	O
.	O

Patients	O
with	O
advanced	O
disease	O
who	O
were	O
insured	O
with	O
Medicare	O
were	O
less	O
likely	O
to	O
receive	O
standard	B:C2936643
-	I:C2936643
of	I:C2936643
-	I:C2936643
care	I:C2936643
postoperative	O
radiotherapy	I:C0436206
and	O
/	O
or	O
chemotherapy	O
than	O
those	O
with	O
private	O
insurance	O
(	O
odds	O
ratio	O
:	O
OR	O
0.80	O
,	O
P	O
<	O
0.001	O
)	O
,	O
as	O
were	O
those	O
residing	O
in	O
the	O
South	O
(	O
reference	O
)	O
in	O
comparison	O
to	O
the	O
Northeast	O
,	O
Atlantic	O
,	O
Great	O
Lakes	I:C0018224
,	O
and	O
Midwest	O
regions	I:C0017446
(	O
OR	O
1.3	O
-	O
1.7	O
,	O
all	O
P	O
<	O
0.001	O
)	O
.	O

Patients	O
with	O
advanced	O
disease	O
who	O
were	O
insured	O
with	O
Medicare	O
were	O
less	O
likely	O
to	O
receive	O
standard	O
-	I:C2936643
of	I:C2936643
-	I:C2936643
care	I:C2936643
postoperative	B:C0436206
radiotherapy	I:C0436206
and	O
/	O
or	O
chemotherapy	O
than	O
those	O
with	O
private	O
insurance	O
(	O
odds	O
ratio	O
:	O
OR	O
0.80	O
,	O
P	O
<	O
0.001	O
)	O
,	O
as	O
were	O
those	O
residing	O
in	O
the	O
South	O
(	O
reference	O
)	O
in	O
comparison	O
to	O
the	O
Northeast	O
,	O
Atlantic	O
,	O
Great	O
Lakes	I:C0018224
,	O
and	O
Midwest	O
regions	I:C0017446
(	O
OR	O
1.3	O
-	O
1.7	O
,	O
all	O
P	O
<	O
0.001	O
)	O
.	O

Patients	O
with	O
advanced	O
disease	O
who	O
were	O
insured	O
with	O
Medicare	O
were	O
less	O
likely	O
to	O
receive	O
standard	O
-	I:C2936643
of	I:C2936643
-	I:C2936643
care	I:C2936643
postoperative	O
radiotherapy	I:C0436206
and	O
/	O
or	O
chemotherapy	B:C3665472
than	O
those	O
with	O
private	O
insurance	O
(	O
odds	O
ratio	O
:	O
OR	O
0.80	O
,	O
P	O
<	O
0.001	O
)	O
,	O
as	O
were	O
those	O
residing	O
in	O
the	O
South	O
(	O
reference	O
)	O
in	O
comparison	O
to	O
the	O
Northeast	O
,	O
Atlantic	O
,	O
Great	O
Lakes	I:C0018224
,	O
and	O
Midwest	O
regions	I:C0017446
(	O
OR	O
1.3	O
-	O
1.7	O
,	O
all	O
P	O
<	O
0.001	O
)	O
.	O

Patients	O
with	O
advanced	O
disease	O
who	O
were	O
insured	O
with	O
Medicare	O
were	O
less	O
likely	O
to	O
receive	O
standard	O
-	I:C2936643
of	I:C2936643
-	I:C2936643
care	I:C2936643
postoperative	O
radiotherapy	I:C0436206
and	O
/	O
or	O
chemotherapy	O
than	O
those	O
with	O
private	O
insurance	O
(	O
odds	O
ratio	O
:	O
OR	O
0.80	O
,	O
P	O
<	O
0.001	O
)	O
,	O
as	O
were	O
those	O
residing	O
in	O
the	O
South	B:C1710133
(	O
reference	O
)	O
in	O
comparison	O
to	O
the	O
Northeast	O
,	O
Atlantic	O
,	O
Great	O
Lakes	I:C0018224
,	O
and	O
Midwest	O
regions	I:C0017446
(	O
OR	O
1.3	O
-	O
1.7	O
,	O
all	O
P	O
<	O
0.001	O
)	O
.	O

Patients	O
with	O
advanced	O
disease	O
who	O
were	O
insured	O
with	O
Medicare	O
were	O
less	O
likely	O
to	O
receive	O
standard	O
-	I:C2936643
of	I:C2936643
-	I:C2936643
care	I:C2936643
postoperative	O
radiotherapy	I:C0436206
and	O
/	O
or	O
chemotherapy	O
than	O
those	O
with	O
private	O
insurance	O
(	O
odds	O
ratio	O
:	O
OR	O
0.80	O
,	O
P	O
<	O
0.001	O
)	O
,	O
as	O
were	O
those	O
residing	O
in	O
the	O
South	O
(	O
reference	O
)	O
in	O
comparison	O
to	O
the	O
Northeast	B:C1709272
,	O
Atlantic	O
,	O
Great	O
Lakes	I:C0018224
,	O
and	O
Midwest	O
regions	I:C0017446
(	O
OR	O
1.3	O
-	O
1.7	O
,	O
all	O
P	O
<	O
0.001	O
)	O
.	O

Patients	O
with	O
advanced	O
disease	O
who	O
were	O
insured	O
with	O
Medicare	O
were	O
less	O
likely	O
to	O
receive	O
standard	O
-	I:C2936643
of	I:C2936643
-	I:C2936643
care	I:C2936643
postoperative	O
radiotherapy	I:C0436206
and	O
/	O
or	O
chemotherapy	O
than	O
those	O
with	O
private	O
insurance	O
(	O
odds	O
ratio	O
:	O
OR	O
0.80	O
,	O
P	O
<	O
0.001	O
)	O
,	O
as	O
were	O
those	O
residing	O
in	O
the	O
South	O
(	O
reference	O
)	O
in	O
comparison	O
to	O
the	O
Northeast	O
,	O
Atlantic	B:C0004166
,	O
Great	O
Lakes	I:C0018224
,	O
and	O
Midwest	O
regions	I:C0017446
(	O
OR	O
1.3	O
-	O
1.7	O
,	O
all	O
P	O
<	O
0.001	O
)	O
.	O

Patients	O
with	O
advanced	O
disease	O
who	O
were	O
insured	O
with	O
Medicare	O
were	O
less	O
likely	O
to	O
receive	O
standard	O
-	I:C2936643
of	I:C2936643
-	I:C2936643
care	I:C2936643
postoperative	O
radiotherapy	I:C0436206
and	O
/	O
or	O
chemotherapy	O
than	O
those	O
with	O
private	O
insurance	O
(	O
odds	O
ratio	O
:	O
OR	O
0.80	O
,	O
P	O
<	O
0.001	O
)	O
,	O
as	O
were	O
those	O
residing	O
in	O
the	O
South	O
(	O
reference	O
)	O
in	O
comparison	O
to	O
the	O
Northeast	O
,	O
Atlantic	O
,	O
Great	B:C0018224
Lakes	I:C0018224
,	O
and	O
Midwest	O
regions	I:C0017446
(	O
OR	O
1.3	O
-	O
1.7	O
,	O
all	O
P	O
<	O
0.001	O
)	O
.	O

Patients	O
with	O
advanced	O
disease	O
who	O
were	O
insured	O
with	O
Medicare	O
were	O
less	O
likely	O
to	O
receive	O
standard	O
-	I:C2936643
of	I:C2936643
-	I:C2936643
care	I:C2936643
postoperative	O
radiotherapy	I:C0436206
and	O
/	O
or	O
chemotherapy	O
than	O
those	O
with	O
private	O
insurance	O
(	O
odds	O
ratio	O
:	O
OR	O
0.80	O
,	O
P	O
<	O
0.001	O
)	O
,	O
as	O
were	O
those	O
residing	O
in	O
the	O
South	O
(	O
reference	O
)	O
in	O
comparison	O
to	O
the	O
Northeast	O
,	O
Atlantic	O
,	O
Great	O
Lakes	I:C0018224
,	O
and	O
Midwest	B:C0017446
regions	I:C0017446
(	O
OR	O
1.3	O
-	O
1.7	O
,	O
all	O
P	O
<	O
0.001	O
)	O
.	O

Those	O
residing	O
in	O
the	O
Mountain	B:C0684035
region	I:C0684035
were	O
even	O
less	O
likely	O
to	O
receive	O
appropriate	O
treatment	O
(	O
OR	O
0.7	O
,	O
P	O
<	O
0.001	O
)	O
.	O

Five	O
-	O
year	O
stage	B:C1300072
IIIC	I:C1300072
/	I:C1300072
IV	I:C1300072
survival	O
was	O
42.8	O
%	O
for	O
non-Hispanic	O
whites	I:C1257890
vs	O
24.6	O
%	O
for	O
blacks	O
(	O
hazard	O
ratio	O
1.3	O
,	O
P	O
<	O
0.001	O
)	O
.	O

Five	O
-	O
year	O
stage	O
IIIC	I:C1300072
/	I:C1300072
IV	I:C1300072
survival	O
was	O
42.8	O
%	O
for	O
non-Hispanic	B:C1257890
whites	I:C1257890
vs	O
24.6	O
%	O
for	O
blacks	O
(	O
hazard	O
ratio	O
1.3	O
,	O
P	O
<	O
0.001	O
)	O
.	O

Five	O
-	O
year	O
stage	O
IIIC	I:C1300072
/	I:C1300072
IV	I:C1300072
survival	O
was	O
42.8	O
%	O
for	O
non-Hispanic	O
whites	I:C1257890
vs	O
24.6	O
%	O
for	O
blacks	B:C0005680
(	O
hazard	O
ratio	O
1.3	O
,	O
P	O
<	O
0.001	O
)	O
.	O

Other	O
factors	O
associated	O
with	O
inferior	O
5	O
-	O
year	O
survival	O
included	O
payer	B:C1257890
status	O
(	O
not	O
insured	O
,	O
Medicaid	O
,	O
Medicare	O
,	O
vs	O
private	O
,	O
ORs	O
1.2	O
-	O
1.3	O
,	O
all	O
P	O
<	O
0.01	O
)	O
,	O
and	O
treatment	O
at	O
low	O
-	I:C1552416
volume	I:C1552416
centers	I:C1552416
(	O
<	O
5	O
vs	O
≥30	O
cases	O
/	O
year	O
,	O
HR	O
1.3	O
,	O
P	O
<	O
0.001	O
)	O
.	O

Other	O
factors	O
associated	O
with	O
inferior	O
5	O
-	O
year	O
survival	O
included	O
payer	O
status	O
(	O
not	O
insured	O
,	O
Medicaid	O
,	O
Medicare	O
,	O
vs	O
private	O
,	O
ORs	O
1.2	O
-	O
1.3	O
,	O
all	O
P	O
<	O
0.01	O
)	O
,	O
and	O
treatment	O
at	O
low	B:C1552416
-	I:C1552416
volume	I:C1552416
centers	I:C1552416
(	O
<	O
5	O
vs	O
≥30	O
cases	O
/	O
year	O
,	O
HR	O
1.3	O
,	O
P	O
<	O
0.001	O
)	O
.	O

Socioeconomic	O
,	O
geographic	O
and	O
facility	O
-	O
related	O
factors	O
predict	O
advanced	B:C0007103
endometrial	I:C0007103
cancer	I:C0007103
stage	O
,	O
failure	O
to	O
receive	O
cancer	O
care	O
,	O
and	O
shorter	O
survival	O
.	O

Socioeconomic	O
,	O
geographic	O
and	O
facility	O
-	O
related	O
factors	O
predict	O
advanced	O
endometrial	I:C0007103
cancer	I:C0007103
stage	B:C1300072
,	O
failure	O
to	O
receive	O
cancer	O
care	O
,	O
and	O
shorter	O
survival	O
.	O

Black	B:C0005680
women	O
had	O
especially	O
poor	O
survival	O
.	O

Black	O
women	B:C0043210
had	O
especially	O
poor	O
survival	O
.	O

Nationwide	B:C0038136
standardization	I:C0038136
and	O
concentration	O
of	O
treatment	O
at	O
high	O
-	I:C1552416
volume	I:C1552416
centers	I:C1552416
may	O
improve	O
outcomes	O
.	O

Nationwide	O
standardization	I:C0038136
and	O
concentration	O
of	O
treatment	O
at	O
high	B:C1552416
-	I:C1552416
volume	I:C1552416
centers	I:C1552416
may	O
improve	O
outcomes	O
.	O

